Search by Drug Name or NDC
NDC 00703-4636-01 Zanosar 100 mg/mL Details
Zanosar 100 mg/mL
Zanosar is a INTRAVENOUS POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is STREPTOZOCIN.
MedlinePlus Drug Summary
Streptozocin is used to treat cancer of the pancreas that has gotten worse or spread to other parts of the body. Streptozocin is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 00703-4636-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Streptozocin
Product Information
| NDC | 00703-4636 |
|---|---|
| Product ID | 0703-4636_086af066-2d97-4c11-9f8d-68eb4f7c29f3 |
| Associated GPIs | 21102030002105 |
| GCN Sequence Number | 008825 |
| GCN Sequence Number Description | streptozocin VIAL 1 G INTRAVEN |
| HIC3 | V1D |
| HIC3 Description | ANTIBIOTIC ANTINEOPLASTICS |
| GCN | 38630 |
| HICL Sequence Number | 003920 |
| HICL Sequence Number Description | STREPTOZOCIN |
| Brand/Generic | Brand |
| Proprietary Name | Zanosar |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | streptozocin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | STREPTOZOCIN |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Pharmaceutical Class | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA050577 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00703-4636-01 (00703463601)
| NDC Package Code | 0703-4636-01 |
|---|---|
| Billing NDC | 00703463601 |
| Package | 10 mL in 1 VIAL (0703-4636-01) |
| Marketing Start Date | 2003-12-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |